Saltar al contenido
Merck

ABCs of Neonatal Cardiac Anesthesia.

Artificial organs (2013-01-12)
Chris Chin
RESUMEN

Congenital heart disease (CHD) is relatively common and there are treatment options for virtually every form of CHD. With good care, the majority of babies can survive to adulthood; however, CHD remains a significant cause of death in infancy and neonates are especially vulnerable. In order to manage these patients, a clear understanding of the underlying pathophysiology and the planned surgical procedure is important. However, attention to detail and meticulous care are equally important, and, in addition, there are several management strategies that may standardize practice and can improve outcome.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Sulfato de magnesio, anhydrous, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Sulfato de magnesio heptahidratado, ACS reagent, ≥98%
Sigma-Aldrich
Sulfato de magnesio, anhydrous, reagent grade, ≥97%
Sigma-Aldrich
Sulfato de magnesio heptahidratado, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Sulfato de magnesio, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Sulfato de magnesio heptahidratado, BioReagent, for molecular biology, suitable for plant cell culture, ≥99.0%
Sigma-Aldrich
Sulfato de magnesio, puriss. p.a., drying agent, anhydrous, ≥98.0% (KT), powder (very fine)
Sigma-Aldrich
Magnesium sulfate solution, for molecular biology, 1.00 M±0.04 M
Sigma-Aldrich
Sulfato de magnesio heptahidratado, BioUltra, ≥99.5% (KT)
Sigma-Aldrich
Magnesium sulfate solution, BioUltra, for molecular biology
Sigma-Aldrich
Sulfato de magnesio heptahidratado, 99.5-100.5% (calc. to the dried substance), meets analytical specification of Ph. Eur., BP,USP, FCC
Sigma-Aldrich
Sulfato de magnesio, ≥99.99% trace metals basis
Sigma-Aldrich
Sulfato de magnesio heptahidratado, puriss. p.a., ACS reagent, ≥99.0% (KT)
Sigma-Aldrich
Sulfato de magnesio heptahidratado, BioXtra, ≥99.0%